m00osfoto / Shutterstock.com
A five-year period of data exclusivity available for biological drugs, as proposed in the Trans-Pacific Partnership (TPP) is long enough to encourage investment in the field, readers have said.
If you have already subscribed please login.
If you have any technical issues please email tech support.
patent, biologics, data exclusivity, Trans-Pacific Partnership, TPP,
